null - FindTrial

Status

Not yet recruiting

Phases

Unknown

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2011-004104-38-ES

Enrollment

Registered

2012-01-19

Start date

2012-02-17

Completion date

Unknown

Last updated

2012-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MedDRA version: 14.1 Level: PT Classification code 10017374 Term: Friedreich's ataxia System Organ Class: 10010331 - Congenital, familial and genetic disorders

Interventions

Trade Name: INCRELEX 10 mg/ml solución inyectable Pharmaceutical Form: Solution for injection INN or Proposed INN: MECASERMIN CAS Number: 68562-41-4 Concentration unit: mg/kg milligram(s)/kilogram Con

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? yes Number of subjects for this age range: 5 F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 20 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 5

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

Spain

Contacts

Public ContactFIBHULP

FIBHULP

fundacion.hulp@salud.madrid.org34917277576

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026